Tag: pharmaceuticals

AstraZeneca logs upbeat trial results from Covid drug

LONDON, United Kingdom (AFP) – British pharmaceuticals giant AstraZeneca on Monday revealed more positive results from a trial of a treatment for Covid-19 symptoms. The drug, made from a combination of two antibodies, achieved a “statistically significant reduction in severe Covid-19 or death” in non-hospitalised patients with mild-to-moderate symptoms, AstraZeneca said in a statement. The group’s treatment, known as AZD7442, has been undergoing phase 3 or final clinical trials to assess its safety and efficacy. […]

Continue Reading →

Pfizer estimates $15 bn in 2021 sales for Covid-19 vaccine

  NEW YORK, United States (AFP) — Sales of the Covid-19 vaccine developed by Pfizer and BioNTech could reach up to $15 billion in 2021 and go higher if Pfizer signs additional supply contracts, Pfizer said Tuesday. The projections came as Pfizer projected full-year 2021 sales of between $59.4 billion and $61.4 billion, meaning that about one-fourth of estimated total sales will come from the Covid-19 vaccine. The forecast reflects “a continued recovery in macroeconomic […]

Continue Reading →

Over 130 virus therapies under investigation: pharma group

GENEVA, Switzerland (AFP) — More than 130 therapies are being investigated as possible treatments for the coronavirus, a leading pharmaceutical industry association said Thursday. Unprecedented efforts to collaborate across the pharmaceutical industry have significantly accelerated the search for safe and effective treatments for the novel coronavirus, the International Federation of Pharmaceutical Manufacturers and Associations said. “Over 130 COVID-19 therapeutics are under investigation,” IFPMA director Thomas Cueni told a virtual briefing, along with a number of pharmaceutical […]

Continue Reading →